---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-304795"
form_type: "8-K"
ticker: "RCEL"
cik: "0001762303"
company_name: "AVITA Medical, Inc."
filed_at: "2022-12-14T23:59:59+00:00"
generated_at: "2026-06-21T04:50:39.561921+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Avita Medical annual meeting: all directors elected, quorum bylaw amendment fails

## Summary
- All five director nominees elected; each received 9.2M-10.4M votes for.
- Ratification of Grant Thornton as independent auditor approved (12.4M for, 224K against).
- Proposal to reduce stockholder meeting quorum failed (9.6M for, 956K against; needed majority of outstanding shares).
- Equity grants to directors Panaccio, Crowe, Curnock Cook, Reed (RSUs+options worth $87.5K+$37.5K each) and CEO Corbett (options worth $1M) approved.
- Non-binding say-on-pay advisory vote passed (7.8M for, 2.4M against).

## SEC filing metadata
- accession: 0001193125-22-304795
- form_type: 8-K
- ticker: RCEL
- cik: 0001762303
- company_name: AVITA Medical, Inc.
- filed_at: 2022-12-14T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.07, 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1762303/000119312522304795/0001193125-22-304795-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1762303/000119312522304795/d387584d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-304795
- JSON: https://secwatch.observer/filing/0001193125-22-304795.json
- Plain text: https://secwatch.observer/filing/0001193125-22-304795.txt

## Key facts
- Shareholder Votes
  AVITA Medical, Inc. shareholders approved Election of Directors at the 2022-12-12 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2022-12-12
  source text: All five directors named in the Company’s Proxy Statement for the Annual Meeting (“Proxy Statement”) were elected to serve on the Company’s Board of Directors with the following vote: Name Votes For Votes Withheld Non-Votes Louis Panaccio ( Chair ) 9,299,761 1,685,226 1,928,912 James Corbett ( Executive Director and CEO ) 10,360,740 624,247 1,928,912 Jeremy Curnock Cook ( Director ) 9,803,894 1,181,093 1,928,912 Professor Suzanne Crowe ( Director ) 9,216,541 1,768,446 1,928,912 Jan Stern Reed ( Director ) 9,926,444 1,058,543 1,928,912
  evidence_url: https://www.sec.gov/Archives/edgar/data/1762303/000119312522304795/0001193125-22-304795-index.htm
- Shareholder Votes
  AVITA Medical, Inc. shareholders approved Issuance of Securities to Mr. James Corbett at the 2022-12-12 meeting.
  - Proposal: equity plan
  - Outcome: passed
  - Meeting: 2022-12-12
  source text: Shareholders approved the grant of options to acquire shares of common stock of the Company (which may be represented by CDIs) equal in value to US$1,000,000 (at the time of the grant) to Mr. James Corbett on the terms and conditions set out in this Proxy Statement, pursuant to and for the purposes of ASX Listing Rule 10.11, by a vote of (i) 8,476,617 in favor, (ii) 1,869,887 against, and (iii) 638,483 abstaining.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1762303/000119312522304795/0001193125-22-304795-index.htm
- Shareholder Votes
  AVITA Medical, Inc. shareholders approved Issuance of Securities to Professor Suzanne Crowe at the 2022-12-12 meeting.
  - Proposal: equity plan
  - Outcome: passed
  - Meeting: 2022-12-12
  source text: Shareholders approved the grant of restricted stock units to acquire shares of common stock of the Company (which may be represented by CDIs) equal in value to US$87,500 (at the time of the grant) and the grant of options to acquire shares of common stock of the Company (which may be represented by CDIs) equal in value to US$37,500 (at the time of the grant) to Professor Suzanne Crowe on the terms and conditions set out in this Proxy Statement, pursuant to and for the purposes of ASX Listing Rule 10.11, by a vote of (i) 7,656,800 in favor, (ii) 2,666,551 against, and (iii) 661,636 abstaining.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1762303/000119312522304795/0001193125-22-304795-index.htm
- Shareholder Votes
  AVITA Medical, Inc. shareholders approved Advisory Vote to Approve Compensation of Named Executive Officers at the 2022-12-12 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2022-12-12
  source text: Shareholders voted in favor of the non-binding advisory vote to approve the compensation of the Company’s named executive officers, by a vote of (i) 7,832,181 in favor, (ii) 2,381,954 against, and (iii) 770,852 abstaining.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1762303/000119312522304795/0001193125-22-304795-index.htm
- Shareholder Votes
  AVITA Medical, Inc. shareholders approved Appointment of Independent Auditors at the 2022-12-12 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2022-12-12
  source text: The appointment of Grant Thornton LLP as the Company’s independent public accountants for the fiscal year ending December 31, 2022, was ratified by a vote of (i) 12,430,789 in favor, (ii) 224,743 against, and (iii) 258,367 abstaining.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1762303/000119312522304795/0001193125-22-304795-index.htm
- Shareholder Votes
  AVITA Medical, Inc. shareholders approved Issuance of Securities to Ms. Jan Stern Reed at the 2022-12-12 meeting.
  - Proposal: equity plan
  - Outcome: passed
  - Meeting: 2022-12-12
  source text: Shareholders approved the grant of restricted stock units to acquire shares of common stock of the Company (which may be represented by CDIs) equal in value to US$87,500 (at the time of the grant) and the grant of options to acquire shares of common stock of the Company (which may be represented by CDIs) equal in value to US$37,500 (at the time of the grant) to Ms. Jan Stern Reed on the terms and conditions set out in this Proxy Statement, pursuant to and for the purposes of ASX Listing Rule 10.11, by a vote of (i) 7,657,643 in favor, (ii) 2,674,563 against, and (iii) 652,781 abstaining.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1762303/000119312522304795/0001193125-22-304795-index.htm
- Shareholder Votes
  AVITA Medical, Inc. shareholders approved Issuance of Securities to Mr. Jeremy Curnock Cook at the 2022-12-12 meeting.
  - Proposal: equity plan
  - Outcome: passed
  - Meeting: 2022-12-12
  source text: Shareholders approved the grant of restricted stock units to acquire shares of common stock of the Company (which may be represented by CDIs) equal in value to US$87,500 (at the time of the grant) and the grant of options to acquire shares of common stock of the Company (which may be represented by CDIs) equal in value to US$37,500 (at the time of the grant) to Mr. Jeremy Curnock Cook on the terms and conditions set out in this Proxy Statement, pursuant to and for the purposes of ASX Listing Rule 10.11, by a vote of (i) 7,612,792 in favor, (ii) 2,745,543 against, and (iii) 626,652 abstaining.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1762303/000119312522304795/0001193125-22-304795-index.htm
- Shareholder Votes
  AVITA Medical, Inc. shareholders approved Issuance of Securities to Mr. Louis Panaccio at the 2022-12-12 meeting.
  - Proposal: equity plan
  - Outcome: passed
  - Meeting: 2022-12-12
  source text: Shareholders approved the grant of restricted stock units to acquire shares of common stock of the Company (which may be represented by CDIs) equal in value to US$87,500 (at the time of the grant) and the grant of options to acquire shares of common stock of the Company (which may be represented by CDIs) equal in value to US$37,500 (at the time of the grant) to Mr. Louis Panaccio on the terms and conditions set out in this Proxy Statement, pursuant to and for the purposes of ASX Listing Rule 10.11, by a vote of (i) 7,637,405 in favor, (ii) 2,735,159 against, and (iii) 612,423 abstaining.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1762303/000119312522304795/0001193125-22-304795-index.htm
- Shareholder Votes
  AVITA Medical, Inc. shareholders rejected Amendments to the Company's Amended and Restated Bylaws to reduce the quorum requirement for stockholder meetings at the 2022-12-12 meeting.
  - Proposal: charter amendment
  - Outcome: failed
  - Meeting: 2022-12-12
  source text: Shareholders did not approve amendments to the Company’s Certificate of Incorporation and Amended and Restated Bylaws to reduce the quorum requirement for stockholder meetings, on the terms and conditions set out in the Proxy Statement, by a vote of (i) 9,587,285 in favor, (ii) 956,344 against, and (iii) 441,358 abstaining.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1762303/000119312522304795/0001193125-22-304795-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.